Mississauga-based Microbix Biosystems Inc. providing quality assessment product to help ensure the accuracy of COVID-19 disease testing
Mississauga-based Microbix Biosystems Inc. created a quality assessment product (QAP™) to help ensure the accuracy of COVID-19 disease testing.
By creating this unique product, Microbix is contributing to the development of new methods and improved methods for SARS-CoV-2 virus (COVID-19) detection and is helping to improve the accuracy of existing protocols by providing reliable, whole-genome validation/verification and training samples.
The product is now available in Canada, the U.S. and Europe.